Stockreport

Roivant Sciences: Moderna Settlement And Brepocitinib Support A Long-Term Buy [Seeking Alpha]

Roivant Sciences Ltd. - Common Shares  (ROIV) 
PDF Brepocitinib is clearly now becoming a broader immunology franchise across DM, NIU, CS, and LPP. ROIV also settled with Moderna regarding LNP, which adds to its alrea [Read more]